REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Lazar Ecuador S.A. Lazarecsa (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Laboratorio Lazar Ecuador S.A. Lazarecsa Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorio Lazar Ecuador S.A. Lazarecsa is based in Ecuador. The head office is in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on August 30, 2005. Laboratorio Lazar Ecuador S.A. Lazarecsa currently employs 36 (2021) people. The latest financial highlights indicate a net sales revenue increase of 4.83% in 2022. Over the same period, its total assets grew by 5.73%. In 2022, Laboratorio Lazar Ecuador S.A. Lazarecsa’s net profit margin decreased by 0.46%.

Headquarters
Av. 9 de Octubre 1904, Condominio Florida P- 602 Bldg. , Floor 600
Guayaquil; Guayas;

Contact Details: Purchase the Laboratorio Lazar Ecuador S.A. Lazarecsa report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Lazar Ecuador S.A. Lazarecsa report to view the information.
Outstanding Shares:
Purchase the Laboratorio Lazar Ecuador S.A. Lazarecsa report to view the information.
Registered Capital:
Purchase the Laboratorio Lazar Ecuador S.A. Lazarecsa report to view the information.
Incorporation Date:
August 30, 2005
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
96%
Purchase this report to view the information.
4%
Company Performance
Financial values in the chart are available after Laboratorio Lazar Ecuador S.A. Lazarecsa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
4.83%
Total operating revenue
7.91%
Operating profit (EBIT)
142.19%
EBITDA
109.13%
Net Profit (Loss) for the Period
-9.83%
Total assets
5.73%
Total equity
35.75%
Operating Profit Margin (ROS)
10.79%
Net Profit Margin
-0.46%
Return on Equity (ROE)
-13.26%
Quick Ratio
-0.02%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?